Grenada

Resilience System


You are here

Global

Extra safety scrutiny planned as virus vaccine worries grow

Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available — an added safety layer experts call vital.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pfizer Says It Won’t Seek Vaccine Authorization Before Mid-November

The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its coronavirus vaccine before the third week of November, ruling out President Trump’s assertion that a vaccine would be ready before Election Day on Nov. 3.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

FDA approveS 1st drug, Inmazeb, for Ebola

U.S. regulators Wednesday approved the first drug for the treatment of Ebola.

The Food and Drug Administration OK’d the drug developed by Regeneron Pharmaceuticals for treating adults and children. It was tested during an outbreak in Congo that killed nearly 2,300 people before it ended in June.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OPINON Essay: As Pandemic Rages on, Some Optimism --NYT science writer srter

 ....Clearly, the pandemic has not ended. So far some 215,000 Americans have lost their lives to the coronavirus, and reliable estimates suggest that the number could reach 400,000. Health experts agree that, with stronger leadership, the death toll would have been far lower.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks
Page loaded in 1.708 seconds.